1887

Journal of General Virology header logo

Volume 86, Issue 1

Transmissible spongiform encephalopathy strain, PrP genotype and brain region all affect the degree of glycosylation of PrP Free

Abstract

Transmissible spongiform encephalopathies (TSEs), sometimes known as prion diseases, are caused by an infectious agent whose molecular properties have not been determined. Traditionally, different strains of TSE diseases are characterized by a series of phenotypic properties after passage in experimental animals. More recently it has been recognized that diversity in the degree to which an abnormal form of the host protein PrP, denoted PrP, is glycosylated and the migration of aglycosyl forms of PrP on immunoblots may have some differential diagnostic potential. It has been recognized that these factors are affected by the strain of TSE agent but also by other factors, e.g. location within the brain. This study shows in some cases, but not others, that host PrP genotype has a major influence on the degree of PrP glycosylation and migration on gels and provides further evidence of the effect of brain location. Accordingly both the degree of glycosylation and the apparent molecular mass of PrP may be of some value for differential diagnosis between TSE strains, but only when host effects are taken into account. Furthermore, the data inform the debate about how these differences arise, and favour hypotheses proposing that TSE agents affect glycosylation of PrP during its biosynthesis.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80251-0
2005-01-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/1/vir860241.html?itemId=/content/journal/jgv/10.1099/vir.0.80251-0&mimeType=html&fmt=ahah

References

  1. Baron T. G., Madec J. Y., Calavas D., Richard Y., Barillet F. 2000; Comparison of French natural scrapie isolates with bovine spongiform encephalopathy and experimental scrapie infected sheep. Neurosci Lett 284:175–178 [CrossRef]
     [Google Scholar]
  2. Bessen R. A., Marsh R. F. 1994; Distinct PrP properties suggest the molecular-basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859–7868
     [Google Scholar]
  3. Bessen R. A., Kocisko D. A., Raymond G. J., Nandan S., Lansbury P. T., Caughey B. 1995; Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375:698–700 [CrossRef]
     [Google Scholar]
  4. Bruce M. E., Dickinson A. G. 1979; Biological stability of different classes of scrapie agent. In Slow Transmissible Diseases of the Central Nervous System pp  71–86 Edited by Prusiner S. B., Hadlow W. J. New York: Academic Press;
     [Google Scholar]
  5. Bruce M. E., Dickinson A. G. 1987; Biological evidence that scrapie agent has an independent genome. J Gen Virol 68:79–89 [CrossRef]
     [Google Scholar]
  6. Bruce M. E., McConnell I., Fraser H., Dickinson A. G. 1991; The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 72:595–603 [CrossRef]
     [Google Scholar]
  7. Bruce M., Chree A., McConnell I., Foster J., Pearson G., Fraser H. 1994; Transmission of bovine spongiform encephalopathy and scrapie to mice – strain variation and the species barrier. Philos Trans R Soc Lond B Biol Sci 343:405–411 [CrossRef]
     [Google Scholar]
  8. Caughey B., Raymond G. J., Bessen R. A. 1998; Strain-dependent differences in β -sheet conformations of abnormal prion protein. J Biol Chem 273:32230–32235 [CrossRef]
     [Google Scholar]
  9. Chandler R. L. 1961; Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1:1378–1379
     [Google Scholar]
  10. Chesebro B. 1998; BSE and prions: uncertainties about the agent. Science 279:42–43 [CrossRef]
     [Google Scholar]
  11. Collinge J., Sidle K. C. L., Meads J., Ironside J., Hill A. F. 1996; Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383:685–690 [CrossRef]
     [Google Scholar]
  12. Dickinson A. G. 1976; Scrapie in sheep and goats. Front Biol 44:209–241
     [Google Scholar]
  13. Dickinson A. G., Meikle V. M., Fraser H. 1968; Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. J Comp Pathol 78:293–299 [CrossRef]
     [Google Scholar]
  14. Farquhar C. F., Somerville R. A., Bruce M. E. 1998; Straining the prion hypothesis. Nature 391:345–346 [CrossRef]
     [Google Scholar]
  15. Goldmann W., O'Neill G., Cheung F., Charleson F., Ford P., Hunter N. 1999; PrP (prion) gene expression in sheep may be modulated by alternative polyadenylation of its messenger RNA. J Gen Virol 80:2275–2283
     [Google Scholar]
  16. Gonzalez L., Martin S., Jeffrey M. 2003; Distinct profiles of PrPd immunoreactivity in the brain of scrapie- and BSE-infected sheep: implications for differential cell targeting and PrP processing. J Gen Virol 84:1339–1350 [CrossRef]
     [Google Scholar]
  17. Hill A. F., Desbruslais M., Joiner S., Sidle K. C., Gowland I., Collinge J., Doey L. J., Lantos P. 1997; The same prion strain causes vCJD and BSE. Nature 389:448–450 [CrossRef]
     [Google Scholar]
  18. Hill A. F., Butterworth R. J., Joiner S. 12 other authors 1999; Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353:183–189 [CrossRef]
     [Google Scholar]
  19. Hope J., Multhaup G., Reekie L. J., Kimberlin R. H., Beyreuther K. 1988; Molecular pathology of scrapie-associated fibril protein (PrP) in mouse brain affected by the ME7 strain of scrapie. Eur J Biochem 172:271–277 [CrossRef]
     [Google Scholar]
  20. Hunter N., Goldmann W., Marshall E., O'Neill G. 2000 Sheep and goats: natural and experimental TSEs and factors influencing incidence of disease Arch Virol Suppl;181–188
     [Google Scholar]
  21. Jeffrey M., Martin S., Gonzalez L. 2003; Cell-associated variants of disease-specific prion protein immunolabelling are found in different sources of sheep transmissible spongiform encephalopathy. J Gen Virol 84:1033–1045 [CrossRef]
     [Google Scholar]
  22. Kascsak R. J., Rubenstein R., Merz P. A., Carp R. I., Wisniewski H. M., Diringer H. 1985; Biochemical differences among scrapie-associated fibrils support the biological diversity of scrapie agents. J Gen Virol 66:1715–1722 [CrossRef]
     [Google Scholar]
  23. Kimberlin R. H., Walker C. 1977; Characteristics of a short incubation model of scrapie in the golden hamster. J Gen Virol 34:295–304 [CrossRef]
     [Google Scholar]
  24. Leblanc P., Baas D., Darlix J. L. 2004; Analysis of the interactions between HIV-1 and the cellular prion protein in a human cell line. J Mol Biol 337:1035–1051 [CrossRef]
     [Google Scholar]
  25. Meyer R. K., McKinley M. P., Bowman K. A., Braunfeld M. B., Barry R. A., Prusiner S. B. 1986; Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U S A 83:2310–2314 [CrossRef]
     [Google Scholar]
  26. Notari S., Capellari S., Giese A., Westner I., Baruzzi A., Ghetti B., Gambetti P., Kretzschmar H. A., Parchi P. 2004; Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem 279:16797–16804 [CrossRef]
     [Google Scholar]
  27. Parchi P., Zou W., Wang W. 10 other authors 2000; Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A 97:10168–10172 [CrossRef]
     [Google Scholar]
  28. Prusiner S. B. 1998; Prions. Proc Natl Acad Sci U S A 95:13363–13383 [CrossRef]
     [Google Scholar]
  29. Schreuder B. E., Somerville R. A. 2003; Bovine spongiform encephalopathy in sheep?. Rev Sci Tech 22:103–120
     [Google Scholar]
  30. Somerville R. A. 1999; Host and transmissible spongiform encephalopathy agent strain control glycosylation of PrP. J Gen Virol 80:1865–1872
     [Google Scholar]
  31. Somerville R. A. 2002; TSE agent strains and PrP: reconciling structure and function. Trends Biochem Sci 27:606–612 [CrossRef]
     [Google Scholar]
  32. Somerville R. A., Ritchie L. A. 1989; Are scrapie associated fibrils a pathological product of infection? In Unconventional Virus Diseases of the Central Nervous System . pp  521–535 Edited by Court L. A., Dormont D., Brown P., Kingsbury D. T. Fauntenay-aux-Roses Cedex: Commissariat à L'Énergie Atomique
  33. Somerville R. A., Chong A., Mulqueen O. U., Birkett C. R., Wood S. C. E. R., Hope J. 1997; Biochemical typing of scrapie strains. Nature 386:564 [CrossRef]
     [Google Scholar]
  34. Somerville R. A., Oberthür R. C., Havekost U., MacDonald F., Taylor D. M., Dickinson A. G. 2002; Characterisation of thermodynamic diversity between transmissible spongiform encephalopathy agent strains. J Biol Chem 277:11084–11089 [CrossRef]
     [Google Scholar]
  35. Stack M. J., Chaplin M. J., Clark J. 2002; Differentiation of prion protein glycoforms from naturally occurring sheep scrapie, sheep-passaged scrapie strains (CH1641 and SSBP1), bovine spongiform encephalopathy (BSE) cases and Romney and Cheviot breed sheep experimentally inoculated with BSE using two monoclonal antibodies. Acta Neuropathol 104:279–286
     [Google Scholar]
  36. Vorberg I., Priola S. A. 2002; Molecular basis of scrapie strain glycoform variation. J Biol Chem 277:36775–36781 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80251-0
Loading
Transmissible spongiform encephalopathy strain, PrP genotype and brain region all affect the degree of glycosylation of PrPSc
J. Gen. Virol. 86, 241 (2005); https://doi.org/10.1099/vir.0.80251-0
/content/journal/jgv/10.1099/vir.0.80251-0
/content/journal/jgv/10.1099/vir.0.80251-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error